Clinical Trial Packaging Market - Global Forecast to 2024
This study will involve the extensive use of both primary and secondary sources. The research process will involve the study of various factors affecting the industry, to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
Secondary research process will include the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. We will conduct secondary research to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the clinical trial packaging market. Secondary research will also give important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. We will also prepare a database of the key industry leaders using secondary research.
Primary Research
In the primary research process, we will conduct interviews with industry experts from both the supply and demand sides to obtain qualitative and quantitative information for this report. Industry experts from the supply side will include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of companies providing clinical trial packaging products, key opinion leaders, whereas, the industry experts from the demand side will include directors of large size organizations, medium size organizations, small size organizations, and related key executives.
Market Size Estimation
The market size estimates and forecasts in this study will be derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product, material type, end user, and region).
Data Triangulation
After arrival at the market size, the total clinical trial packaging market will be divided into several segments. We will employ data triangulation and market breakdown procedures to complete the overall market engineering process and arrive at the exact statistics for all segments.
Objectives of the Study
- To define, describe, and forecast the clinical trial packaging market on the basis of product, material type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To forecast the size of the clinical trial packaging market with respect to—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
- To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders
- To profile key players in the clinical trial packaging market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as product launches and enhancements; mergers and acquisitions; expansions; and collaborations, agreements, & partnerships of the leading players in the clinical trial packaging market
Want to explore hidden markets that can drive new revenue in Clinical Trial Packaging Market?
Scope of the Report:
Want to explore hidden markets that can drive new revenue in Clinical Trial Packaging Market?
|
Report Metric |
Details |
|
Market size will be provided in the report |
2017–2024 |
|
Base year for consideration |
2018 |
|
Forecast period |
2019–2024 |
|
Forecast units |
Value (USD) |
|
List of indicative segments to be included in the study |
Product segments such as syringes, bottles, blisters, tubes, vials and ampoules, bags and pouches, sachets, kits or packs, and others |
|
List of indicative geographies to be included in the study |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. |
|
List of indicative companies to be included in the study |
PAREXEL International Corporation (US), Fisher Clinical Services, Inc. (US), The Coghlan Group, Inc. (US), Mawdsley-Brooks & Co. Ltd (UK), Piramal Enterprises Ltd (India), Sharp (UK), Corden Pharma GmbH (Germany), Bilcare Limited (India), Westrock Company (US), Sentry BioPharma Services (US), PCI Pharma Services (US), NextPharma Technologies Holding Limited (UK), and Körber Medipak Systems AG (Germany) |
The research report will categorize the market into the following segments and subsegments:
Clinical Trial Packaging Market, By Product
- Syringes
- Bottles
- Blisters
- Cold Forming
- Thermoforming
- Tubes
- Vials and Ampoules
- Bags and Pouches
- Sachets
- Kits or Packs
- Others
Clinical Trial Packaging Market, By Material Type
- Plastic
- Polyvinyl Chloride (PVC)
- Polyethylene (PE)
- High Density Polyethylene (HDPE)
- Low Density Polyethylene (LDPE)
- Polypropylene (PP)
- Others
- Glass
- Metal
- Paper
- Corrugated Fiber
Clinical Trial Packaging Market, By End User
- Drug Manufacturing Companies
- Research Laboratories
- Clinical Research Organizations
Clinical Trial Packaging Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- Italy
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
Customizations
With the given market data, MarketsandMarkets can offer customizations as per the company’s specific needs. The following customization options will be available for the report:
Company Information
- Detailed analysis and profiling of additional market players (5 Players)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific clinical trial packaging market into Australia, South Korea, Malaysia, and others
- Further breakdown of the Middle East & Africa clinical trial packaging market into Saudi Arabia, South Africa, and others
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.2.1 Secondary Sources
2.2.2 Primary Sources
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Clinical Trial Packaging Market Overview
4.2 Asia Pacific: Clinical Trial Packaging Market, By Material Type
4.3 Geographic Snapshot of the Clinical Trial Packaging Market (2017)
4.4 Geographic Mix: Clinical Trial Packaging Market, 2018-2023 (USD Million)
4.5 Clinical Trial Packaging Market: Developing vs Developed Markets, 2018 vs 2023 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Challenges
6 Industry Insights
6.1 Industry Trends
6.2 Regulatory Analysis
7 Clinical Trial Packaging Market, By Product
7.1 Introduction
7.2 Syringes
7.3 Bottles
7.4 Blisters
7.4.1 Cold Forming
7.4.2 Thermoforming
7.5 Tubes
7.6 Vials and Ampoules
7.7 Bags and Pouches
7.8 Sachets
7.9 Kits Or Packs
7.1 Others
8 Clinical Trial Packaging Market, By Material Type
8.1 Introduction
8.2 Plastic
8.2.1 Polyvinyl Chloride (PVC)
8.2.2 Polyethylene (PE)
8.2.2.1 High Density Polyethylene (HDPE)
8.2.2.2 Low Density Polyethylene (LDPE)
8.2.2.3 Polypropylene (PP)
8.2.3 Others
8.3 Glass
8.4 Metal
8.5 Paper
8.6 Corrugated Fiber
9 Clinical Trial Packaging Market, By End User
9.1 Introduction
9.2 Drug Manufacturing Companies
9.3 Research Laboratories
9.4 Clinical Research Organizations
10 Clinical Trial Packaging Market, By Region/Country
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 Italy
10.3.3 Spain
10.3.4 France
10.3.5 UK
10.3.6 Rest of Europe (RoE)
10.4 Asia Pacific (APAC)
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific (RoAPAC)
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America (Rolatm)
10.6 Middle East & Africa
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, By Key Players (2017)
11.3 Competitive Leadership Mapping, 2018
11.3.1 Visionary Leaders
11.3.2 Visionary Leaders
11.3.3 Emerging Companies
11.3.4 Dynamic Differentiators
11.4 Competitive Situation and Trends
11.4.1 Product Launches
11.4.2 Collaborations, Agreements, & Partnerships
11.4.3 Mergers & Acquisitions
11.4.4 Expansions
12 Company Profiles
(Business Overview, Financials, Products Offered, Recent Developments, and MnM View)
12.1 Parexel International Corporation
12.2 Fisher Clinical Services, Inc.
12.3 The Coghlan Group, Inc.
12.4 Mawdsley-Brooks & Co. Ltd
12.5 Piramal Enterprises Ltd
12.6 Sharp
12.7 Corden Pharma GmbH
12.8 Bilcare Limited
12.9 Westrock Company
12.10 Sentry Biopharma Services
12.11 Pci Pharma Services
12.12 Nextpharma Technologies Holding Limited
12.13 Körber Medipak Systems AG
13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details
Note:
The Factors Mentioned in the Toc are Based on Preliminary Research and May Vary in the Final Report
The List of Companies Mentioned Above is Indicative Only and Might Change During the Course of the Study
Top 13 Leading Market Players Would Be Profiles in the Report
Details on Key Financials Might Not Be Captured in Case of Unlisted Companies
Growth opportunities and latent adjacency in Clinical Trial Packaging Market